AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 6, 2002, Pages 2568-2574

  Halonen, Maria ^a   Eskelin, Petra ^b   Myhre, Anne Grethe ^c   Perheentupa, Jaakko ^d   Husebye, Eystein S ^e   Kämpe, Olle ^f   Rorsman, Fredrik ^a   Peltonen, Leena ^b   Ulmanen, Ismo ^c   Partanen, Jukka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^f FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADDISON DISEASE; ALOPECIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CHROMOSOME 21Q; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GENE MUTATION; GENOTYPE; HLA SYSTEM; HUMAN; HYPOPARATHYROIDISM; MAJOR CLINICAL STUDY; MUCOCUTANEOUS CANDIDIASIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL;

EID: 18444378139     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.6.8564     Document Type: Article

References (51)

1. Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED): Autosomal recessive inheritance
2. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients
3. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients
4. Polyglandular autoimmune syndrome type I among Iranian Jews
5. Autoimmune polyglandular syndrome type 1
6. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway
7. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains
8. Positional cloning of the APECED gene
9. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common co-activator CREB-binding protein
10. Mutations in the AIRE gene: Effects on sub-cellular location and transactivation function of the APECED protein
11. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla
12. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse
13. Subcellular location and expression pattern of autoimmune regulator (Aire) - The mouse ortholog for human gene defective in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
14. Normal thymic architecture and negative selection are associated with aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
15. Type 1 autoimmune polyglandular disease
16. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease
17. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure
18. Pteridin-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type I
19. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
20. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure
21. Identification of tryptophan hydroxylase as an intestinal autoantigen
22. Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I
23. APECED mutations in the autoimmune regulator (AIRE) gene
24. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type 1 autoimmune polyglandular syndrome
25. The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR
26. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity
27. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I
28. Blot hybridisation analysis of genomic DNA
29. Genetic homogeneity of autoimmune polyglandular disease type I
30. ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
31. Nonsense-mediated mRNA decay in health and disease
32. Complexity in a monogenic disease
33. Single gene disorders or complex traits: Lessons from the thalassaemias and other monogenic diseases
34. Modifier genes in humans: Strategies for identification
35. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13
36. Genetic predisposition to autoimmune endocrine diseases
37. Genetic analysis of autoimmune disease
38. HLA associations with autoimmune Addison's disease
39. DRB1*04 and DQ alleles: Expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease
40. Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility
41. Steroid 21-hydroxylase gene polymorphism in Addison's disease patients
42. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease
43. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients
44. Reevaluation of the importance of polymorphic HLA class II alleles and amino acids in the susceptibility of individuals of different populations to type I diabetes
45. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes
46. Molecular basis for HLA-DQ associations with IDDM
47. Exceptional stability of the HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC molecule associated with protection from insulin-dependent diabetes mellitus
48. 5′ Insulin gene polymorphism confers risk to IDDM independently of HLA class II susceptibility
49. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved?
50. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis
51. Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)